Comparative proteomics analysis of LCM purified nasopharyngeal carcinoma and normal nasopharyngeal epithelial tissue

Progress in Biochemistry and Biophysics

Volumn 35, Issue 5, 2008, Pages 521-530

  Cheng, Ai Lan ^a   Huang, Wei Guo ^a   Zhang, Peng Fei ^a   Li, Mao Yu ^a   Peng, Fang ^a   Li, Feng ^a   Li, Cui ^a   Yi, Hong ^a   Li, Mei Xiang ^a   Chen, Zhu Chu ^a   Xiao, Zhi Qiang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

ESI Q TOF MS; Immunohistochemistry; Laser capture microdissection; MALDI TOF MS; Nasopharyngeal carcinoma; Proteome; Two dimensional gel electrophoresis; Western blot

Indexed keywords

EID: 48249107108     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Yu M C, Yuan J M. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol, 2002, 12(6): 421-429
2. Yokes E E, Liebowitz D N, Weichselbaum R R. Nasopharyngeal carcinoma. Lancet, 1997, 350 (9084): 1087-1091
3. Ahmad A, Stefani S. Distant metastases of nasopharyngeal carcinoma: a study of 245 male patients. J Surg Oncol, 1986, 33(3): 194-197
4. Wong M M, Lye M S, Cheng H M, et al. Epstein-Barr virus serology in the diagnosis of of nasopharyngeal carcinoma. Asian Pac J Allergy Immunol, 2005, 23(1): 65-67
5. Cho W C, Yip T T, Yip C, et al. Identification of serum amyloid a protein as a potentially useful biomarker to monitor relapse of nasopharyngeal carcinoma by serum proteomic profiling. Clin Cancer Res, 2004, 10(1): 43-52
6. Song L B, Zeng M S, Liao W T, et al. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res, 2006, 66(12): 6225-6232
7. Qian C N, Guo X, Cao B, et al. Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma. Cancer Research, 2002, 62(2): 589-596
8. Sriuranpong V, Mutirangura A, Gillespie J W, et al. Global gene expression profile of nasopharyngeal carcinoma by laser capture microdissection and complementary DNA microarrays. Clin Cancer Res, 2004, 10(15): 4944-4958
9. Emmert-Buck M R, Bonner R F, Smith P D, et al. Laser capture microdissection. Science, 1996, 274(5289): 998-1001
10. Neubauer H, Clare S E, Kurek R, et al. Breast cancer proteomics by laser capture microdissection, sample pooling, 54-cm IPG IEF, and differential iodine radioisotope detection. Electrophoresis, 2006, 27 (9): 1840-1852
11. Li C, Hong Y, Tan Y X, et al. Accurate qualitative and quantitative proteomic analysis of clinical hepatocellular carcinoma using laser capture microdissection coupled with isotope-coded affinity tag and two-dimensional liquid chromatography mass spectrometry. Mol Cell Proteomics, 2004, 3(4): 399-409
12. Shekouh A R, Thompson C C, Prime W, et al. Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma. Proteomics, 2003, 3 (10): 1988-2001
13. Hara A, Okayasu I. Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance. Acta Neuropathol, 2004, 108(1): 43-48
14. Chen Z C, Liang S P. Tumor Proteomics. 1st. Changsha, Hunan: Hunan Science Technique Press, 2002. 1-7
15. Moll R, Franke W W, Schiller D L, et al. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell, 1982, 31(1): 11-24
16. Godfroid E, Geuskens M, Dupressoir T, et al. Cytokeratins are exposed on the outer surface of established human mammary carcinoma cells. J Cell Sci, 1991, 99(3): 595-607
17. Hembrough T A, Vasudevan J, Allietta M M, et al. A cytokeratin 8-like protein with plasminogenbinding activity is present on the external surfaces of hepatocytes, HepG2 cells and breast carcinoma cell lines. J Cell Sci, 1995, 108(3): 1071-1082
18. Fukunaga Y, Bandoh S, Fujita J, et al. Expression of cytokeratin 8 in lung cancer cell lines and measurement of serum cytokeratin 8 in lung cancer patients. Lung Cancer, 2002, 38(1): 31-38
19. Schaafsma H E, Ramaekers F C S, van Muijen G N P, et al. Cytokeratin expression patterns in metastatic transitional cell carcinoma of the urinary tract. Am J Pathol, 1991, 139(6): 1389-1400
20. Schaafsma H E, van der Velden L A, Manni J J, et al. Increased expression of cytokeratin 8, 18 and vimentin in the invasion front of mucosal squamous cell carcinoma. J Pathol, 1993, 170(1): 77-86
21. Fujita J, Dobashi N, Ohtsuki Y, et al. Detection of large molecular weight cytokeratin 8 as carrier protein of CA19-9 in non-small-cell lung cancer cell lines. Br J Cancer, 1999, 81(5): 769-773